Apelin is a positive regulator of ace2 in failing hearts

Journal of Clinical Investigation

Volumn 123, Issue 12, 2013, Pages 5203-5211

  Sato, Teruki ^a   Suzuki, Takashi ^a   Watanabe, Hiroyuki ^a   Kadowaki, Ayumi ^a   Fukamizu, Akiyoshi ^b   Liu, Peter P ^c   Kimura, Akinori ^d   Ito, Hiroshi ^a   Penninger, Josef M ^e   Imai, Yumiko ^a   Kuba, Keiji ^a  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; APELIN; APELIN RECEPTOR; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE CONTRACTILITY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; ONCOGENE RAS; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; UPREGULATION;

ANGIOTENSIN I; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION; HEART FAILURE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PROMOTER REGIONS, GENETIC; RAS PROTEINS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, G-PROTEIN-COUPLED; RECOMBINANT FUSION PROTEINS; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 84890090677     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI69608     Document Type: Article

References (53)

1. Szokodi I, et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res. 2002;91(5):434-440
2. Berry MF, et al. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation. 2004;110(11 suppl 1):II187-II193
3. O'Dowd BF, et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene. 1993; 136(1-2):355-360
4. Tatemoto K, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun. 1998; 251(2):471-476
5. Lee DK, et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem. 2000;74(1):34-41
6. Reaux A, et al. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem. 2001;77(4):1085-1096
7. Chen MM, et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation. 2003;108(12):1432-1439
8. Ashley EA, et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res. 2005; 65(1):73-82
9. Japp AG, et al. Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure. Circulation. 2010;121(16):1818-1827
10. Kuba K, et al. Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload. Circ Res. 2007;101(4):e32-e42
11. Charo DN, et al. Endogenous regulation of cardiovascular function by apelin-APJ. Am J Physiol Heart Circ Physiol. 2009;297(5):H1904-H1913
12. Scimia MC, et al. APJ acts as a dual receptor in cardiac hypertrophy. Nature. 2012;488(7411):394-398
13. Donoghue M, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000;87(5):E1-E9
14. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensinconverting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000;275(43):33238-33243
15. Vickers C, et al. Hydrolysis of biological peptides by human angiotensin-converting enzymerelated carboxypeptidase. J Biol Chem. 2002; 277(17):14838-14843
16. Crackower MA, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417(6891):822-828
17. Yamamoto K, et al. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Hypertension. 2006;47(4):718-726
18. Oudit GY, et al. Angiotensin II-mediated oxidativestress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res. 2007;75(1):29-39
19. Oudit GY, et al. Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol. 2006;168(6):1808-1820
20. Tikellis C, et al. ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes. 2008;57(4):1018-1025
21. Imai Y, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112-116
22. Kuba K, Imai Y, Ohto-Nakanishi T, Penninger JM. Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther. 2010; 128(1):119-128
23. Li W, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450-454
24. Kuba K, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875-879
25. Hashimoto T, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487(7408):477-481
26. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI. Counterregulatory actions of angiotensin-(1-7). Hypertension. 1997;30(3 pt 2):535-541
27. Ferreira AJ, et al. Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases. Hypertension. 2010; 55(2):207-213
28. Santos RA, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A. 2003;100(14):8258-8263
29. McLean DL, et al. Apelin/APJ signaling is a critical regulator of statin effects in vascular endothelial cells - brief report. Arterioscler Thromb Vasc Biol. 2012;32(11):2640-2643
30. Nozaki Y, Sato N, Iida T, Hara K, Fukuyama K, Epstein WL. Prolyl endopeptidase purified from granulomatous inflammation in mice. J Cell Biochem. 1992;49(3):296-303
31. Odya CE, Marinkovic DV, Hammon KJ, Stewart TA, Erdos EG. Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney. J Biol Chem. 1978;253(17):5927-5931
32. Chappell MC, Gomez MN, Pirro NT, Ferrario CM. Release of angiotensin-(1-7) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition. Hypertension. 2000;35(1 pt 2):348-352
33. Yamamoto K, Chappell MC, Brosnihan KB, Ferrario CM. In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension. 1992; 19(6 pt 2):692-696
34. Foussal C, et al. Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy. FEBS Lett. 2010;584(11):2363-2370
35. Iwanaga Y, Kihara Y, Takenaka H, Kita T. Downregulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin 2-angiotensin type 1 receptor system. J Mol CellCardiol. 2006;41(5):798-806.
36. Chun HJ, et al. Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest. 2008;118(10):3343-3354.
37. Siddiquee K, Hampton J, McAnally D, May L, Smith L. The apelin receptor inhibits the angiotensin 2 type 1 receptor via allosteric trans-inhibition. Br J Pharmacol. 2013;168(5):1104-1117.
38. Santos RA, Ferreira AJ, Verano-Braga T, Bader M. Angiotensin-converting enzyme 2, angiotensin- (1-7) and Mas: new players of the renin-angiotensin system. J Endocrinol. 2013;216(2):R1-R17.
39. Chou CF, et al. ACE2 orthologues in non-mammalian vertebrates (Danio, Gallus, Fugu, Tetraodon and Xenopus). Gene. 2006;377:46-55.
40. Jiang Y, Evans T. The Xenopus GATA-4/5/6 genes are associated with cardiac specification and can regulate cardiac-specific transcription during embryogenesis. Dev Biol. 1996;174(2):258-270.
41. Inui M, Fukui A, Ito Y, Asashima M. Xapelin and Xmsr are required for cardiovascular development in Xenopus laevis. Dev Biol. 2006;298(1):188-200.
42. Scott IC, et al. The g protein-coupled receptor agtrl1b regulates early development of myocardial progenitors. Dev Cell. 2007;12(3):403-413.
43. Zeng XX, Wilm TP, Sepich DS, Solnica-Krezel L. Apelin and its receptor control heart field formation during zebrafish gastrulation. Dev Cell. 2007; 12(3):391-402.
44. Red-Horse K, Ueno H, Weissman IL, Krasnow MA. Coronary arteries form by developmental reprogramming of venous cells. Nature. 2010;464(7288):549-553.
45. Paskaradevan S, Scott IC. The Aplnr GPCR regulates myocardial progenitor development via a novel cellnon- autonomous, Galpha(i/o) protein-independent pathway. Biol Open. 2012;1(3):275-285
46. Gersh BJ, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124(24):2761-2796
47. Zhong J, et al. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation. 2010;122(7):717-728
48. Sugaya T, et al. Angiotensin II type 1a receptordeficient mice with hypotension and hyperreninemia. J Biol Chem. 1995;270(32):18719-18722.
49. Ishida J, et al. Regulatory roles for APJ, a seventransmembrane receptor related to angiotensintype 1 receptor in blood pressure in vivo. J Biol Chem. 2004;279(25):26274-26279.
50. Nishida M, et al. G alpha 12/13- and reactive oxygen species-dependent activation of c-Jun NH2- terminal kinase and p38 mitogen-activated protein kinase by angiotensin receptor stimulation in rat neonatal cardiomyocytes. J Biol Chem. 2005; 280(18):18434-18441.
51. Senkel S, Lucas B, Klein-Hitpass L, Ryffel GU. Identification of target genes of the transcription factor HNF1beta and HNF1alpha in a human embryonic kidney cell line. Biochim Biophys Acta. 2005; 1731(3):179-190.
52. Day RM, et al. Hepatocyte growth factor regulates angiotensin converting enzyme expression. J Biol Chem. 2004;279(10):8792-8801.
53. Yuki K, et al. Mitochondrial dysfunction increases expression of endothelin-1 and induces apoptosis through caspase-3 activation in rat cardiomyocytes in vitro. J Cardiovasc Pharmacol. 2000; 36(5 suppl 1):S205-S208